Easyfive-TT
Description
Easy five contains Diphtheria toxoid, Tetanus toxoid, whole cell Pertussis vaccine, Hepatitis B surface antigen and conjugated Haemophilus influenzae type b (Hib) vaccine. Easyfive is indicated for primary active immunization against Diphtheria, Tetanus, Pertussis, Haemophilus influenzae type b (meningitis, septicaemia, cellulitis, arthritis, epiglottitis, etc) infections and Hepatitis B (HB) in infants from 6 weeks onwards.
Immunization guideline:
DTP-Hep B-Hib vaccine can be given in a 3 dose schedule at 6, 10 and 14 weeks after the monovalent Hep B birth dose. Pentavalent vaccines are not recommended for DTP Booster doses.
For latest IAP updates see revised immunization schedule.
Additional information
vaccine-type | Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus Type b (PRP-TT) |
---|---|
manufacturer | Panacea Biotec |
country-of-manufacture | India |
pharmaceutical-form | Liquid |
route-of-administration | Intramuscular |
package-size | 1 Dose |
preservative | Thiomersal |
Contraindications | Easyfive-TT should not be administered to children having central nervous system disorders, hypersensitivity to any component of the vaccine, or having shown signs of hypersensitivity after previous administration of diphtheria, tetanus, pertussis, Hib or HB vaccines. It is contra-indicated if the child has experienced an encephalopathy, occurring within 7 days following previous vaccination with pertussis containing vaccine. In these circumstances the vaccination course should be continued with DT, Hib and HB vaccines. |